Nyrada Inc. (NYR.AX)

AUD 0.1

(-2.0%)

Operating Expenses Summary of Nyrada Inc.

  • Nyrada Inc.'s latest annual operating expenses in 2024 was 4.55 Million AUD , down -50.18% from previous year.
  • Nyrada Inc.'s latest quarterly operating expenses in 2024 FY was 4.55 Million AUD , down -50.18% from previous quarter.
  • Nyrada Inc. reported a annual operating expenses of 9.14 Million AUD in annual operating expenses 2023, up 88.25% from previous year.
  • Nyrada Inc. reported a annual operating expenses of 4.85 Million AUD in annual operating expenses 2022, down -13.29% from previous year.
  • Nyrada Inc. reported a quarterly operating expenses of 4.55 Million AUD for 2024 FY, down -50.18% from previous quarter.
  • Nyrada Inc. reported a quarterly operating expenses of 2.29 Million AUD for 2024 Q2, down 0.0% from previous quarter.

Annual Operating Expenses Chart of Nyrada Inc. (2024 - 2018)

Historical Annual Operating Expenses of Nyrada Inc. (2024 - 2018)

Year Operating Expenses Operating Expenses Growth
2024 4.55 Million AUD -50.18%
2023 9.14 Million AUD 88.25%
2022 4.85 Million AUD -13.29%
2021 5.6 Million AUD -14.32%
2020 6.53 Million AUD 67.59%
2019 3.9 Million AUD 81.1%
2018 2.15 Million AUD 0.0%

Peer Operating Expenses Comparison of Nyrada Inc.

Name Operating Expenses Operating Expenses Difference
EZZ Life Science Holdings Limited 39.57 Million AUD 88.49%
Anatara Lifesciences Ltd 710.21 Thousand AUD -541.377%
Zelira Therapeutics Limited 5.94 Million AUD 23.423%
Biome Australia Limited 7.91 Million AUD 42.421%
Patrys Limited 4.93 Million AUD 7.665%
Orthocell Limited 15.36 Million AUD 70.362%
Imugene Limited 135.09 Million AUD 96.628%
Noxopharm Limited 7 Million AUD 34.928%
PYC Therapeutics Limited 60.91 Million AUD 92.522%
Chimeric Therapeutics Limited 19.76 Million AUD 76.956%
Prescient Therapeutics Limited 10.89 Million AUD 58.205%
Proteomics International Laboratories Limited 892.14 Thousand AUD -410.587%
Cynata Therapeutics Limited 11.12 Million AUD 59.049%
CSL Limited 7.56 Billion AUD 99.94%
Arovella Therapeutics Limited 10.78 Million AUD 57.765%
Bio-Gene Technology Limited 2.76 Million AUD -64.982%
Clinuvel Pharmaceuticals Limited 31.29 Million AUD 85.445%
Starpharma Holdings Limited 22.81 Million AUD 80.035%
Nanollose Limited 12.5 Thousand AUD -36338.429%
Memphasys Limited 3.67 Million AUD -23.836%
Invex Therapeutics Ltd 3.34 Million AUD -36.142%
NeuroScientific Biopharmaceuticals Limited 1.96 Million AUD -131.789%
Amplia Therapeutics Limited 8.43 Million AUD 46.001%
Botanix Pharmaceuticals Limited 601.82 Thousand AUD -656.899%
Island Pharmaceuticals Limited 4.12 Million AUD -10.419%
Race Oncology Limited 14.77 Million AUD 69.16%
Telix Pharmaceuticals Limited 269.26 Million AUD 98.308%
Dimerix Limited 25.64 Million AUD 82.236%
PharmAust Limited 6.65 Million AUD 31.573%
Immutep Limited 42.87 Million AUD 89.376%
Clarity Pharmaceuticals Ltd 56.3 Million AUD 91.91%
Alterity Therapeutics Limited 23.4 Million AUD 80.539%
BTC Health Limited -1.03 Million AUD 538.449%
Acrux Limited 8.55 Million AUD 46.723%
Neuren Pharmaceuticals Limited 32.69 Million AUD 86.069%
Biotron Limited 5.11 Million AUD 10.87%
Tissue Repair Ltd 6.66 Million AUD 31.674%
AdAlta Limited 6.76 Million AUD 32.711%
Radiopharm Theranostics Limited 299.22 Thousand AUD -1422.307%
Hexima Limited 1 Million AUD -351.566%
AnteoTech Limited 12.18 Million AUD 62.623%
Paradigm Biopharmaceuticals Limited 65.1 Million AUD 93.003%
Recce Pharmaceuticals Ltd 21.68 Million AUD 78.993%
Avecho Biotechnology Limited 4.54 Million AUD -0.215%
Actinogen Medical Limited 22.77 Million AUD 79.995%
Immuron Limited 9.13 Million AUD 50.151%
Argenica Therapeutics Limited 8.26 Million AUD 44.914%